StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Stock Performance
NASDAQ:CPIX opened at $1.31 on Wednesday. The firm has a market capitalization of $18.59 million, a PE ratio of -2.22 and a beta of 0.20. The company has a quick ratio of 1.26, a current ratio of 1.44 and a debt-to-equity ratio of 0.62. Cumberland Pharmaceuticals has a 12-month low of $1.20 and a 12-month high of $2.36. The firm has a 50-day moving average price of $1.32 and a 200 day moving average price of $1.47.
Cumberland Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Cumberland Pharmaceuticals
- How to Use Stock Screeners to Find Stocks
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.